Tuesday, 18 March 2014

Managing the side effects of novel cancer immunotherapeutics

In a recent review article, Drs Tara Gangadhar and Robert Vonderheide of the Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA, describe the adverse-event profiles for several novel immune therapy approaches for cancer, and discuss the appropriate management of patients receiving these therapies. Read more here.

No comments:

Post a Comment